Extramedullary disease in multiple myeloma: a systematic literature review
J Bladé, M Beksac, J Caers, A Jurczyszyn… - Blood Cancer …, 2022 - nature.com
Extramedullary involvement (or extramedullary disease, EMD) represents an aggressive
form of multiple myeloma (MM), characterized by the ability of a clone and/or subclone to …
form of multiple myeloma (MM), characterized by the ability of a clone and/or subclone to …
Machine learning and deep learning applications in multiple myeloma diagnosis, prognosis, and treatment selection
Simple Summary Multiple myeloma is a malignant neoplasm of plasma cells with complex
pathogenesis. With major progresses in multiple myeloma research, it is essential that we …
pathogenesis. With major progresses in multiple myeloma research, it is essential that we …
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma
LJ Costa, S Chhabra, E Medvedova… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The MASTER trial combined daratumumab, carfilzomib, lenalidomide, and
dexamethasone (Dara-KRd) in newly diagnosed multiple myeloma (NDMM), using minimal …
dexamethasone (Dara-KRd) in newly diagnosed multiple myeloma (NDMM), using minimal …
The evolving view of thermogenic fat and its implications in cancer and metabolic diseases
X Yin, Y Chen, R Ruze, R Xu, J Song… - Signal Transduction and …, 2022 - nature.com
The incidence of metabolism-related diseases like obesity and type 2 diabetes mellitus has
reached pandemic levels worldwide and increased gradually. Most of them are listed on the …
reached pandemic levels worldwide and increased gradually. Most of them are listed on the …
Comparison of MRI features of fat fraction and ADC for early treatment response assessment in participants with multiple myeloma
Background An imaging-based predictor of response could provide prognostic information
early during treatment course in patients with multiple myeloma (MM). Purpose To …
early during treatment course in patients with multiple myeloma (MM). Purpose To …
Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT
FE Lecouvet, MC Vekemans, T Van Den Berghe… - Skeletal radiology, 2022 - Springer
Bone imaging has been intimately associated with the diagnosis and staging of multiple
myeloma (MM) for more than 5 decades, as the presence of bone lesions indicates …
myeloma (MM) for more than 5 decades, as the presence of bone lesions indicates …
Circulating tumour cells, cell free DNA and tumour-educated platelets as reliable prognostic and management biomarkers for the liquid biopsy in multiple myeloma
Simple Summary Even though the presently employed biomarkers in the detection and
management of multiple myeloma are demonstrating encouraging results, the mortality …
management of multiple myeloma are demonstrating encouraging results, the mortality …
99mTc-CD3813: A Nanobody-Based Single Photon Emission Computed Tomography Radiotracer with Clinical Potential for Myeloma Imaging and Evaluation of …
L Shi, B Chen, T Liu, L Li, B Hu, C Li, B Jia… - Molecular …, 2022 - ACS Publications
Daratumumab (DARA) is an anti-CD38 monoclonal antibody for the treatment of multiple
myeloma (MM). The tumor CD38 expression level is one of the important factors in …
myeloma (MM). The tumor CD38 expression level is one of the important factors in …
Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in multiple myeloma: clinical experience
Objective: In this study, we aimed to compare [68Ga] FAPI PET/CT and [18F] FDG PET/CT
imaging to detect lesions in multiple myeloma. Methods: A total of 14 patients with multiple …
imaging to detect lesions in multiple myeloma. Methods: A total of 14 patients with multiple …
[HTML][HTML] Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma-a potential imaging biomarker for disease prognosis
Beyond being a key factor for tumor growth and metastasis in human cancer, CXC motif
chemokine receptor 4 (CXCR4) is also highly expressed by a number of immune cells …
chemokine receptor 4 (CXCR4) is also highly expressed by a number of immune cells …